Cargando…

Particles that fight cancer: the use of protons and carbon ions in cancer therapy

<!--HTML--><p><span style="font-size:16px"><strong>Particles that fight cancer: the use of protons and carbon ions in cancer therapy </strong></span></p> <p>Cancer is a major societal issue. A key challenge for cancer therapy is the complex...

Descripción completa

Detalles Bibliográficos
Autor principal: CERN. Geneva
Lenguaje:eng
Publicado: 2014
Materias:
Acceso en línea:http://cds.cern.ch/record/1971183
Descripción
Sumario:<!--HTML--><p><span style="font-size:16px"><strong>Particles that fight cancer: the use of protons and carbon ions in cancer therapy </strong></span></p> <p>Cancer is a major societal issue. A key challenge for cancer therapy is the complex and multifaceted nature of the disease, which calls for personalised treatment. Radiotherapy has been used to treat tumours for more than a century, and is still a staple in oncology: today, 50 % of cancer patients receive radiotherapy, half of them with curative intent.</p> <p>Hadrontherapy is one of the most technologically advanced methods of delivering radiation dose to the tumour while protecting surrounding healthy tissues. In addition, hadrontherapy can reach otherwise difficult to access deep-seated tumours and can be used for radio resistant tumours as in hypoxia.</p> <p>This year marks 60 years since the first patient was treated with protons in the US and 20 years since the use of carbon ions in Japan. Join us in learning about the journey of particle therapy in Japan and Europe, its challenges, clinical results and future prospects.</p> <p><strong>Thursday 20th November&nbsp; </strong>16:00 &ndash; 18:00<br /> <strong>CERN Main auditorium<br /> ( </strong>Entrance free &ndash; Limited number of seats)</p> <p>&nbsp;Coffee at 15:30</p> <p>&nbsp;</p> <p><span style="font-size:16px">The Speakers....</span></p> <p><img alt="" src="https://indico.cern.ch/event/350487/picture/4.jpg" /></p> <p><strong><span style="font-size:18px">Prof. Roberto Orecchia </span></strong><br /> Head of department of Radiotherapy, European Institute of Oncology, Milan, Italy<br /> Scientific director of the CNAO foundation, Pavia, Italy</p> <p>&nbsp;</p> <p>&nbsp;</p> <p><img alt="" src="https://indico.cern.ch/event/350487/picture/9.jpg" /></p> <p><span style="font-size:16px"><strong>Prof. Jens Overgaard</strong></span><br /> MD DMSc, Head of department<br /> Department of Experimental Clinical Oncology<br /> Aarhus University Hospital, Denmark</p> <p>&nbsp;</p> <p>&nbsp;</p> <p><img alt="" src="https://indico.cern.ch/event/350487/picture/6.jpg" /></p> <p><span style="font-size:16px"><strong>Prof. Hirohiko Tsujii</strong></span><br /> Director of the Research Center for Charged Particle Therapy, at the National Institute of Radiological Sciences (NIRS), Chiba, Japan</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p>